# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-22-026195
Filing Date
2022-10-11
Accepted
2022-10-11 08:35:06
Documents
15
Period of Report
2022-10-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | aqst-20221011.htm iXBRL | 8-K | 36197
2 | EX-99.1 | a5847396_releasexpreview.htm | EX-99.1 | 13436
6 |  | a5847396_releasexpreview001.jpg | GRAPHIC | 356319
7 |  | a5847396_releasexpreview002.jpg | GRAPHIC | 308277
| Complete submission text file | 0001628280-22-026195.txt |  | 1111300

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | aqst-20221011.xsd | EX-101.SCH | 1893
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | aqst-20221011_lab.xml | EX-101.LAB | 24831
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | aqst-20221011_pre.xml | EX-101.PRE | 13037
9 | EXTRACTED XBRL INSTANCE DOCUMENT | aqst-20221011_htm.xml | XML | 11254

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 221302466
SIC: 2834 Pharmaceutical Preparations